These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


489 related items for PubMed ID: 14617795

  • 1. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer.
    Liao X, Zhang L, Thrasher JB, Du J, Li B.
    Mol Cancer Ther; 2003 Nov; 2(11):1215-22. PubMed ID: 14617795
    [Abstract] [Full Text] [Related]

  • 2. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
    Zhang JS, Herreros-Villanueva M, Koenig A, Deng Z, de Narvajas AA, Gomez TS, Meng X, Bujanda L, Ellenrieder V, Li XK, Kaufmann SH, Billadeau DD.
    Cell Death Dis; 2014 Mar 27; 5(3):e1142. PubMed ID: 24675460
    [Abstract] [Full Text] [Related]

  • 3. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB.
    J Biol Chem; 2004 Sep 17; 279(38):39541-54. PubMed ID: 15252041
    [Abstract] [Full Text] [Related]

  • 4. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.
    Deeb D, Jiang H, Gao X, Hafner MS, Wong H, Divine G, Chapman RA, Dulchavsky SA, Gautam SC.
    Mol Cancer Ther; 2004 Jul 17; 3(7):803-12. PubMed ID: 15252141
    [Abstract] [Full Text] [Related]

  • 5. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B.
    Endocrinology; 2004 Jun 17; 145(6):2941-9. PubMed ID: 14988390
    [Abstract] [Full Text] [Related]

  • 6. GSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells.
    Wu YY, Hsieh CT, Chiu YM, Chou SC, Kao JT, Shieh DC, Lee YJ.
    PLoS One; 2018 Jun 17; 13(12):e0208094. PubMed ID: 30557366
    [Abstract] [Full Text] [Related]

  • 7. Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells.
    Lashinger LM, Zhu K, Williams SA, Shrader M, Dinney CP, McConkey DJ.
    Cancer Res; 2005 Jun 01; 65(11):4902-8. PubMed ID: 15930312
    [Abstract] [Full Text] [Related]

  • 8. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T.
    Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639
    [Abstract] [Full Text] [Related]

  • 9. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K, Douglas L, Delaney A, Houghton JA.
    Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455
    [Abstract] [Full Text] [Related]

  • 10. Sensitization to gimatecan-induced apoptosis by tumor necrosis factor-related apoptosis inducing ligand in prostate carcinoma cells.
    Perego P, Ciusani E, Gatti L, Carenini N, Corna E, Zunino F.
    Biochem Pharmacol; 2006 Mar 14; 71(6):791-8. PubMed ID: 16438941
    [Abstract] [Full Text] [Related]

  • 11. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D, Jiang H, Gao X, Al-Holou S, Danyluk AL, Dulchavsky SA, Gautam SC.
    J Pharmacol Exp Ther; 2007 May 14; 321(2):616-25. PubMed ID: 17289836
    [Abstract] [Full Text] [Related]

  • 12. Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis.
    Deeb DD, Jiang H, Gao X, Divine G, Dulchavsky SA, Gautam SC.
    J Exp Ther Oncol; 2005 May 14; 5(2):81-91. PubMed ID: 16471035
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
    Secchiero P, Milani D, Gonelli A, Melloni E, Campioni D, Gibellini D, Capitani S, Zauli G.
    J Leukoc Biol; 2003 Aug 14; 74(2):223-32. PubMed ID: 12885939
    [Abstract] [Full Text] [Related]

  • 14. Ionizing radiation can induce GSK-3beta phosphorylation and NF-kappaB transcriptional transactivation in ATM-deficient fibroblasts.
    Kwon O, Kim KA, He L, Kim SO, Kim MS, Cha EY, Yoon BD, Sok DE, Jung M, Ahn JS, Kim BY.
    Cell Signal; 2008 Apr 14; 20(4):602-12. PubMed ID: 18243662
    [Abstract] [Full Text] [Related]

  • 15. Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice.
    Xia Y, Rao J, Yao A, Zhang F, Li G, Wang X, Lu L.
    Eur J Pharmacol; 2012 Dec 15; 697(1-3):117-25. PubMed ID: 23051669
    [Abstract] [Full Text] [Related]

  • 16. Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases.
    Harper N, Farrow SN, Kaptein A, Cohen GM, MacFarlane M.
    J Biol Chem; 2001 Sep 14; 276(37):34743-52. PubMed ID: 11461927
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
    Wang HM, Zhang T, Li Q, Huang JK, Chen RF, Sun XJ.
    Neurochem Int; 2013 Nov 14; 63(5):345-53. PubMed ID: 23871716
    [Abstract] [Full Text] [Related]

  • 18. Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression.
    Kim KM, Song JJ, An JY, Kwon YT, Lee YJ.
    J Biol Chem; 2005 Dec 09; 280(49):41047-56. PubMed ID: 16199534
    [Abstract] [Full Text] [Related]

  • 19. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
    Dai Y, Liu M, Tang W, Li Y, Lian J, Lawrence TS, Xu L.
    BMC Cancer; 2009 Nov 06; 9():392. PubMed ID: 19895686
    [Abstract] [Full Text] [Related]

  • 20. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
    Ban JO, Oh JH, Son SM, Won D, Song HS, Han SB, Moon DC, Kang KW, Song MJ, Hong JT.
    Cancer Biol Ther; 2011 Aug 15; 12(4):288-96. PubMed ID: 21613824
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.